Markers of prolonged hospitalisation in severe dengue

PLoS Negl Trop Dis. 2024 Jan 30;18(1):e0011922. doi: 10.1371/journal.pntd.0011922. eCollection 2024 Jan.

Abstract

Background: Dengue is one of the most common diseases in the tropics and subtropics. Whilst mortality is a rare event when adequate supportive care can be provided, a large number of patients get hospitalised with dengue every year that places a heavy burden on local health systems. A better understanding of the support required at the time of hospitalisation is therefore of critical importance for healthcare planning, especially when resources are limited during major outbreaks.

Methods: Here we performed a retrospective analysis of clinical data from over 1500 individuals hospitalised with dengue in Vietnam between 2017 and 2019. Using a broad panel of potential biomarkers, we sought to evaluate robust predictors of prolonged hospitalisation periods.

Results: Our analyses revealed a lead-time bias, whereby early admission to hospital correlates with longer hospital stays - irrespective of disease severity. Importantly, taking into account the symptom duration prior to hospitalisation significantly affects observed associations between hospitalisation length and previously reported risk markers of prolonged stays, which themselves showed marked inter-annual variations. Once corrected for symptom duration, age, temperature at admission and elevated neutrophil-to-lymphocyte ratio were found predictive of longer hospitalisation periods.

Conclusion: This study demonstrates that the time since dengue symptom onset is one of the most significant predictors for the length of hospital stays, independent of the assigned severity score. Pre-hospital symptom durations need to be accounted for to evaluate clinically relevant biomarkers of dengue hospitalisation trajectories.

MeSH terms

  • Biomarkers
  • Hospitalization
  • Humans
  • Length of Stay
  • Retrospective Studies
  • Severe Dengue* / diagnosis
  • Severe Dengue* / epidemiology

Substances

  • Biomarkers

Grants and funding

TPV, LHS, NLT, NTT, NXH, and NMT acknowledge the PAN-ASEAN Coalition for Epidemic and Outbreak Preparedness (PACE-UP) (DAAD Project ID: 57592343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.